The way I understand these things is, as part of the Long Term Incentive Plan, Cyclopharm has issued the shares to an employee as a no cost loan. Yes, this does signal a high degree of confidence that approval will be granted and that the shares will move much higher on the news. What I can't work out is, how did they determine the price of $3.04?
Also, thinking we will hear the FDA decision news on the 29th and not before.
Ann: Application for quotation of securities - CYC, page-3
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
0.010(0.58%) |
Mkt cap ! $191.1M | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.72 | $1.72 | $7.501K | 4.361K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5014 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.72 | 10182 | 2 |
View Market Depth
| Last trade - 12.05pm 14/10/2024 (20 minute delay) ? |
| CYC (ASX) Chart |